Trial
NCT04403763
Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AbbVie
Collaborators
—
Condition
Presbyopia
Intervention
AGN-241622
Why stopped
Strategic considerations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-06